Inscripta

Inscripta, Inc. was a Boulder, Colorado digital genome engineering company founded in 2015 that built the Onyx benchtop platform — an automated CRISPR instrument, consumables, assays and a cloud-based Inscripta Engineering Portal that let scientists design and track millions of precise single-cell genome edits in one experiment. It licensed the MAD7 nuclease, acquired Infinome Biosciences and Sestina Bio in 2023 to pivot toward sustainable biomanufacturing, and merged with Manus (Manus Bio) in April 2025 to form an end-to-end bioalternatives company. Inscripta publishes no public API, developer portal, or machine-readable specification; its only public developer artifact is BioCantor, an MIT-licensed Python genome-annotation library on PyPI and GitHub. inscripta.com now serves a single merger landing page pointing at manusbio.com.

Inscripta is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genome Engineering, Synthetic Biology, and CRISPR.

Inscripta’s developer surface includes engineering blog, support, and 12 more developer resources.

🌐 Visit website 📡 Source on GitHub

9.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyGenome EngineeringSynthetic BiologyCRISPRLife SciencesBioinformaticsBiomanufacturingLaboratory Instruments

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 9.4/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 2.3 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/inscripta: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 3

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

SourceCode

SourceCode

Packages

Packages

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 3

Status, limits, changes, and where to get help

IssueTracker

IssueTracker

Releases

Releases

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

License

License

Company 3

The organization behind the API

Website

Website

Blog

Blog

LinkedIn

Other 2

Properties that don't map to a standard resource type

Successor

Successor

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: inscripta
name: Inscripta
description: Inscripta, Inc. was a Boulder, Colorado digital genome engineering company founded in 2015 that built the Onyx
  benchtop platform — an automated CRISPR instrument, consumables, assays and a cloud-based Inscripta Engineering Portal that
  let scientists design and track millions of precise single-cell genome edits in one experiment. It licensed the MAD7 nuclease,
  acquired Infinome Biosciences and Sestina Bio in 2023 to pivot toward sustainable biomanufacturing, and merged with Manus
  (Manus Bio) in April 2025 to form an end-to-end bioalternatives company. Inscripta publishes no public API, developer portal,
  or machine-readable specification; its only public developer artifact is BioCantor, an MIT-licensed Python genome-annotation
  library on PyPI and GitHub. inscripta.com now serves a single merger landing page pointing at manusbio.com.
url: https://raw.githubusercontent.com/api-evangelist/inscripta/refs/heads/main/apis.yml
image: https://cdn.prod.website-files.com/6536fe08e98c41581598326f/6682ee89aa355ed6e2dca105_Manus%20Social%20Image.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline-2026-08-04
x-status: merged
x-successor: Manus (Manus Bio, Inc.)
x-successor-url: https://www.manusbio.com/
x-api-surface: none
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Biotechnology
- Genome Engineering
- Synthetic Biology
- CRISPR
- Life Sciences
- Bioinformatics
- Biomanufacturing
- Laboratory Instruments
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: IssueTracker
  url: https://github.com/InscriptaLabs/BioCantor/issues
- type: Releases
  url: https://github.com/InscriptaLabs/BioCantor/releases
- type: License
  name: MIT
  url: https://github.com/InscriptaLabs/BioCantor/blob/main/LICENSE
- type: DomainSecurity
  url: security/inscripta-domain-security.yml
- type: Website
  url: https://www.inscripta.com/
- type: Successor
  url: https://www.manusbio.com/
- type: GitHubOrganization
  url: https://github.com/InscriptaLabs
- type: Blog
  url: https://www.manusbio.com/insights-and-news
- type: Support
  url: https://www.manusbio.com/contact
- type: SecondaryMarket
  url: https://forgeglobal.com/inscripta_stock/
- type: LinkedIn
  url: https://www.linkedin.com/company/inscriptainc
- type: SourceCode
  url: https://github.com/InscriptaLabs/BioCantor
- type: Packages
  url: packages/inscripta-packages.yml
- type: LLMsTxt
  url: llms/inscripta-llms.txt
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 4
  pass: local-v1